Cite
HARVARD Citation
Saeki, H. et al. (2022). Difamilast, a selective phosphodiesterase 4 inhibitor, ointment in paediatric patients with atopic dermatitis: a phase III randomized double‐blind, vehicle‐controlled trial. British journal of dermatology. pp. 40-49. [Online].